Reconcile

Fluoxetine, the active ingredient in Reconcile, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral tablet for oral use. It works by increasing serotonin levels in the brain and is indicated for the treatment of major depressive disorder, obsessive‑compulsive disorder, bulimia nervosa, panic disorder, and premenstrual dysphoric disorder in adult patients.

GNH USA supplies Reconcile as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across global markets and patients.

Fluoxetine, an SSRI, acts on serotonergic pathways to alleviate symptoms across several psychiatric and eating‑disorder conditions.

- Major depressive disorder: reduces depressive symptoms and improves mood in adults. - Obsessive‑compulsive disorder: lessens intrusive thoughts and compulsive behaviors. - Bulimia nervosa: decreases binge‑eating episodes and associated urges. - Panic disorder: lowers frequency and intensity of panic attacks. - Premenstrual dysphoric disorder: alleviates mood swings and physical discomfort linked to the menstrual cycle.

Fluoxetine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Insomnia: difficulty falling or staying asleep. - Headache: transient cranial discomfort. - Dry mouth: reduced salivary flow. - Diarrhea: loose stools. - Sexual dysfunction: decreased libido or delayed orgasm.

Serious or Rare Side Effects: - Suicidal thoughts: emergence of suicidal ideation, especially in young adults. - Serotonin syndrome: agitation, hyperthermia, and muscle rigidity. - Hyponatremia: low blood sodium levels causing confusion. - Bleeding risk: increased tendency to bruise or bleed. - Allergic reactions: rash, itching, or swelling.

Before initiating fluoxetine therapy, consider the following safety measures.

- Pregnancy: discuss potential risks with a healthcare professional; data are limited. - Breastfeeding: evaluate infant exposure versus maternal benefit. - Concomitant MAO inhibitors: ensure a minimum 14‑day washout period. - History of bipolar disorder: monitor for mood switching to mania. - Liver or renal impairment: dose adjustment may be required. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Fluoxetine can interact with several medication classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Thioridazine: may cause cardiac arrhythmias. - Pimozide: increased risk of QT prolongation.

Moderate Interactions (Monitor Closely): - Warfarin: potential enhancement of anticoagulant effect. - NSAIDs or aspirin: heightened bleeding tendency. - Carbamazepine: may reduce fluoxetine plasma levels.